855 ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER von van t Klooster, G.A.E, Vanwelkenhuysen, I, Hooijmaijers, R, Bol, K, Voets, M, Van Houdt, J, Verloes, R.A.L, Aharchi, F, Marien, K, Van Remoortere, P, Broeckaert, F, De Kock, H, Simmen, K.A

Volltext

TFIID is required for in vitro transcription of the human U6 gene by RNA polymerase III von Simmen, K.A., Bernués, J., Parry, H.D., Stunnenberg, H.G., Berkenstam, A., Cavallini, B., Egly, J.M., Mattaj, I.W.

Volltext

Common and unique transcription factor requirements of human U1 and U6 snRNA genes von Bernués, J., Simmen, K.A., Lewis, J.D., Gunderson, S.I., Polycarpou‐Schwarz, M., Moncollin, V., Egly, J.M., Mattaj, I.W.

Volltext